|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/42 |
| (11) | Number of the document | 2552441 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11715329.6 |
| Date of filing the European patent application | 2011-03-29 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/030234 |
| Date | 2011-03-29 |
| (87) | Number | WO 2011/123401 |
| Date | 2011-10-06 |
| (30) | Number | Date | Country code |
| 318814 P | 2010-03-30 | US |
| (72) |
MEYERS, Charles, US
SERRANO-WU, Michael H., US
THUREN, Tom, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USES OF DGAT1 INHIBITORS |
| USES OF DGAT1 INHIBITORS |